The development of anticyclic citrullinated peptide (anti‐CCP) antibody following severe COVID‐19
Objectives The dysregulated immune response is one of the cardinal features of severe coronavirus disease 2019 (COVID‐19). This study was conducted to clarify the occurrence of autoantibodies (AABs) associated with systemic autoimmune rheumatic diseases (SARDs) in hospitalized patients with a modera...
Saved in:
Published in | Immunity, Inflammation and Disease Vol. 12; no. 5; pp. e1276 - n/a |
---|---|
Main Authors | , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
John Wiley & Sons, Inc
01.05.2024
John Wiley and Sons Inc Wiley |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!